4 Results for "

MNNG-HOS

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "MNNG-HOS" in MCE Product Catalog:

Cat. No.: HY-178989
CAS No.: 3054148-68-1
Research Areas:  

Cancer

PGK1-IN-2 (Compound 60) is a PGK1 inhibitor with an IC50 of 8.24 μM. PGK1-IN-2 demonstrates a significant ability to inhibit the proliferation of osteosarcoma cells. PGK1-IN-2 interferes with the glycolytic pathway of tumor cells by inhibiting PGK1. PGK1-IN-2 inhibits cell migration and invasion, and induces cell S phase and G2-M phase cycle arrest. PGK1-IN-2 may kill cells by inducing cuproptosis. PGK1-IN-2 shows a significant anti-tumor effect in the MNNG-HOS osteosarcoma xenograft mouse model. PGK1-IN-2 can be used for the study of osteosarcoma .
loading...
    loading...
Cat. No.: HY-115996
CAS No.: 3035774-65-0
Target:  

Apoptosis

Research Areas:  

Cancer

Antitumor agent-51 possesses potent and selective inhibitory for osteosarcoma cell growth and migration with IC50 of 21.9 nM in MNNG/HOS cells. Antitumor agent-51 has a considerable bioavailability and a low toxicity .
loading...
    loading...
Cat. No.: HY-174240
Target:  

Drug Derivative

Research Areas:  

Cancer

Anticancer agent 274 (Compound 1) is a Sorafenib (HY-10201) analog. Anticancer agent 274 can inhibit the growth of tumor cells, with IC50 values of 0.034 μM and 0.042 μM against SaOS-2 and MNNG-HOS cells, respectively. Anticancer agent 274 has relatively low toxicity to normal cells and can be used in the research of tumors such as osteosarcoma .
loading...
    loading...
Cat. No.: HY-50683S
CAS No.: 1936472-36-4
JNJ-38877605-d1 (compound DO-2) is a highly selective MNNG HOS transforming (MET) inhibitor. JNJ-38877605-d1 is thought to diminish the formation of the Aldehyde Oxidase 1 inactive metabolite M3 .
loading...
    loading...